Cargando…

Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis

OBJECTIVE: To validate the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic ductal adenocarcinoma (PDAC) in a Chinese cohort of radically resected patients and to develop a refined staging system for PDAC. METHODS: Data were collected from the China Pancreas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hao, Qu, Chang, Tang, Bingjun, Liu, Weikang, Ma, Yongsu, Chen, Yiran, Xie, Xuehai, Zhuang, Yan, Gao, Hongqiao, Tian, Xiaodong, Yang, Yinmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435826/
https://www.ncbi.nlm.nih.gov/pubmed/34584371
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.04.03
_version_ 1783751880688533504
author Hu, Hao
Qu, Chang
Tang, Bingjun
Liu, Weikang
Ma, Yongsu
Chen, Yiran
Xie, Xuehai
Zhuang, Yan
Gao, Hongqiao
Tian, Xiaodong
Yang, Yinmo
author_facet Hu, Hao
Qu, Chang
Tang, Bingjun
Liu, Weikang
Ma, Yongsu
Chen, Yiran
Xie, Xuehai
Zhuang, Yan
Gao, Hongqiao
Tian, Xiaodong
Yang, Yinmo
author_sort Hu, Hao
collection PubMed
description OBJECTIVE: To validate the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic ductal adenocarcinoma (PDAC) in a Chinese cohort of radically resected patients and to develop a refined staging system for PDAC. METHODS: Data were collected from the China Pancreas Data Center (CPDC) for patients with resected PDAC in 2016 and 2017, and cancer-specific survival (CSS) was evaluated using the Kaplan-Meier method and log-rank test. Univariate and multivariate analyses based on Cox regression were performed to identify prognostic factors. The recursive partitioning analysis (RPA), Kaplan-Meier method, and log-rank test were performed on the training dataset to generate a proposed modification for the 8th TNM staging system utilizing the preoperative carbohydrate antigen (CA)19-9 level. Validation was performed for both staging systems in the validation cohort. RESULTS: A total of 1,676 PDAC patients were retrieved, and the median CSS was significantly different between the 8th TNM groupings, with no significant difference in survival between stage IB and IIA. The analysis of T and N stages demonstrated a better prognostic value in the N category. Multivariate analysis showed that the preoperative serum CA19-9 level was the strongest prognostic indicator among all the independent risk factors. All patients with CA19-9 >500 U/mL had similar survival, and we proposed a new staging system by combining IB and IIA and stratifying all patients with high CA19-9 into stage III. The modified staging system had a better performance for predicting CSS than the 8th AJCC staging scheme. CONCLUSIONS: The 8th AJCC staging system for PDAC is suitable for a Chinese cohort of resected patients, and the N category has a better prognostic value than the T category. Our modified staging system has superior accuracy in predicting survival than the 8th AJCC TNM staging system.
format Online
Article
Text
id pubmed-8435826
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-84358262021-09-27 Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis Hu, Hao Qu, Chang Tang, Bingjun Liu, Weikang Ma, Yongsu Chen, Yiran Xie, Xuehai Zhuang, Yan Gao, Hongqiao Tian, Xiaodong Yang, Yinmo Chin J Cancer Res Original Article OBJECTIVE: To validate the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic ductal adenocarcinoma (PDAC) in a Chinese cohort of radically resected patients and to develop a refined staging system for PDAC. METHODS: Data were collected from the China Pancreas Data Center (CPDC) for patients with resected PDAC in 2016 and 2017, and cancer-specific survival (CSS) was evaluated using the Kaplan-Meier method and log-rank test. Univariate and multivariate analyses based on Cox regression were performed to identify prognostic factors. The recursive partitioning analysis (RPA), Kaplan-Meier method, and log-rank test were performed on the training dataset to generate a proposed modification for the 8th TNM staging system utilizing the preoperative carbohydrate antigen (CA)19-9 level. Validation was performed for both staging systems in the validation cohort. RESULTS: A total of 1,676 PDAC patients were retrieved, and the median CSS was significantly different between the 8th TNM groupings, with no significant difference in survival between stage IB and IIA. The analysis of T and N stages demonstrated a better prognostic value in the N category. Multivariate analysis showed that the preoperative serum CA19-9 level was the strongest prognostic indicator among all the independent risk factors. All patients with CA19-9 >500 U/mL had similar survival, and we proposed a new staging system by combining IB and IIA and stratifying all patients with high CA19-9 into stage III. The modified staging system had a better performance for predicting CSS than the 8th AJCC staging scheme. CONCLUSIONS: The 8th AJCC staging system for PDAC is suitable for a Chinese cohort of resected patients, and the N category has a better prognostic value than the T category. Our modified staging system has superior accuracy in predicting survival than the 8th AJCC TNM staging system. AME Publishing Company 2021-08-31 /pmc/articles/PMC8435826/ /pubmed/34584371 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.04.03 Text en Copyright ©2021Chinese Journal of Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Original Article
Hu, Hao
Qu, Chang
Tang, Bingjun
Liu, Weikang
Ma, Yongsu
Chen, Yiran
Xie, Xuehai
Zhuang, Yan
Gao, Hongqiao
Tian, Xiaodong
Yang, Yinmo
Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis
title Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis
title_full Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis
title_fullStr Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis
title_full_unstemmed Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis
title_short Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis
title_sort validation and modification of the ajcc 8th tnm staging system for pancreatic ductal adenocarcinoma in a chinese cohort: a nationwide pancreas data center analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435826/
https://www.ncbi.nlm.nih.gov/pubmed/34584371
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.04.03
work_keys_str_mv AT huhao validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT quchang validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT tangbingjun validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT liuweikang validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT mayongsu validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT chenyiran validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT xiexuehai validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT zhuangyan validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT gaohongqiao validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT tianxiaodong validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis
AT yangyinmo validationandmodificationoftheajcc8thtnmstagingsystemforpancreaticductaladenocarcinomainachinesecohortanationwidepancreasdatacenteranalysis